Correlation Between Merck and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Merck and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and Organogenesis Holdings, you can compare the effects of market volatilities on Merck and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and Organogenesis Holdings.
Diversification Opportunities for Merck and Organogenesis Holdings
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Merck and Organogenesis is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Merck i.e., Merck and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Merck and Organogenesis Holdings
Considering the 90-day investment horizon Merck Company is expected to under-perform the Organogenesis Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 5.39 times less risky than Organogenesis Holdings. The stock trades about -0.1 of its potential returns per unit of risk. The Organogenesis Holdings is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest 295.00 in Organogenesis Holdings on August 28, 2024 and sell it today you would earn a total of 109.00 from holding Organogenesis Holdings or generate 36.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Merck Company vs. Organogenesis Holdings
Performance |
| Timeline |
| Merck Company |
| Organogenesis Holdings |
Merck and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Merck and Organogenesis Holdings
The main advantage of trading using opposite Merck and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.| Merck vs. Capricor Therapeutics | Merck vs. Soleno Therapeutics | Merck vs. Bio Path Holdings | Merck vs. Moleculin Biotech |
| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |